Levaquin Package Insert PDF
Please note that the following package insert is dated 9/2008 and does not carry the new black box warning.
The new black box warning for Levaquin is as follows:
WARNING
Fluoroquinolones, including LEVAQUIN® (levofloxacin) , are associated with an increased risk of tendinitis and tendon rupture in all ages. This risk is further increased in older patients usually over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart or lung transplants [See WARNINGS AND PRECAUTIONS].
Fluoroquinolones, including LEVAQUIN® (levofloxacin) , may exacerbate muscle weakness in persons with myasthenia gravis. Avoid LEVAQUIN® (levofloxacin) in patients with a known history of myasthenia gravis [See WARNINGS AND PRECAUTIONS].
